Education
About Us
Working with TipRanks
Follow Us
Phibro Animal Health (PAHC)
NASDAQ:PAHC
Earnings Data
Report Date
Feb 11, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.68Last Year’s EPS
0.54Same Quarter Last Year
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted robust growth in the Animal Health segment, strong overall financial performance, and successful new product launches, leading to an increased earnings guidance. However, challenges include a decline in Performance Products and increased corporate expenses. The unchanged revenue guidance despite strong Q1 results suggests some caution moving forward.Company Guidance
Animal Health Sales Growth
Animal Health sales grew by 55%, with an 85% increase in Animal Health adjusted EBITDA, driven by 81% growth in Medicated Feed Additives (MFA).
Strong Overall Financial Performance
Consolidated net sales increased by 40% to $363.9 million. Adjusted EBITDA increased by 102%, adjusted net income increased by 112%, and adjusted diluted EPS increased by 108%.
Vaccine and Nutritional Specialties Growth
Vaccine net sales grew by 25% and Nutritional Specialties net sales increased by 13%, driven by demand for microbial and companion animal products.
New Product Launch
The launch of Restoris, a proprietary dental gel for dogs, marks a significant milestone in the companion animal strategy.
Increased Guidance for Fiscal Year 2026
Adjusted EBITDA guidance increased to $230 million to $240 million, representing a 25% to 30% growth, and adjusted net income guidance increased to $108 million to $115 million.
PAHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PAHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $41.15 | $43.04 | +4.59% |
Aug 27, 2025 | $32.09 | $38.33 | +19.45% |
May 07, 2025 | $19.23 | $22.07 | +14.77% |
Feb 05, 2025 | $22.08 | $24.26 | +9.87% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Phibro Animal Health (PAHC) report earnings?
Phibro Animal Health (PAHC) is schdueled to report earning on Feb 11, 2026, After Close (Confirmed).
What is Phibro Animal Health (PAHC) earnings time?
Phibro Animal Health (PAHC) earnings time is at Feb 11, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PAHC EPS forecast?
PAHC EPS forecast for the fiscal quarter 2026 (Q2) is 0.68.